The respiratory and cardiovascular effects of selective kappa opioid agonists were compared following microinjection (0.1 ~1) into the nucleus ambiguus (NA) and the nucleus tractus solitarius (NTS) regions of spontaneously breathing and artificially respired pentobarbital-anesthetized rats. In spontaneously breathing animals, the benzomorphan derivative MRZ 2549 (MRZ, 3 X 10-i' to 16 x lo-' mol) elicited dose-related decreases of mean arterial pressure (MAP), heart rate (HR), and tidal volume (TV) following NA injection; bremazocine (BREM) decreased MAP, HR, and respiratory rate (RR). Following NTS injection, MRZ (3 x 10-i' to 16 x lo-' mol) lowered MAP and TV, the highest dose also lowering HR and RR; BREM (3 x lo-' to 16 x lo-' mol) decreased MAP and HR. Naloxone (200 pg/kg, i.v.) reversed the respiratory effects of MRZ without consistently altering cardiovascular activity. In ventilated animals, NA injections of MRZ or BREM (3 x 10m9 to 16 x lo-' mol) elicited a dose-related decrease of MAP without altering HR. These responses were not reversed by naloxone. The stereoisomer of BREM (+ BREM) was without effect at similar doses (3 x lo-' to 16 x lo-' mol). MRZ (16 X lo-' mol) elicited a naloxone-reversible tachycardia following NTS injection in ventilated animals; no other cardiovascular responses were observed following NTS administration of BREM (16 x 10m9 mol) or lower doses of MRZ. Dynorphin (l-13) (6 X 10e9 to 60 X lop9 mol) significantly lowered MAP without altering HR following NA microinjections in ventilated animals; the lower dose decreased MAP following NTS injections. These observations suggest that in the NA, the benzomorphan derivatives elicit cardiovascular depressor responses mediated by kappa opioid receptors, whereas the naloxone-sensitive respiratory depression may be mediated in part by mu receptors in the NTS and NA. The selective responses to dynorphin (l-13) in the NTS and NA may indicate the presence of subgroups of kappa receptors in these nuclei.
The respiratory and cardiovascular effects of selective kappa opioid agonists were compared following microinjection (0.1 ~1) into the nucleus ambiguus (NA) and the nucleus tractus solitarius (NTS) regions of spontaneously breathing and artificially respired pentobarbital-anesthetized rats. In spontaneously breathing animals, the benzomorphan derivative MRZ 2549 (MRZ, 3 X 10-i' to 16 x lo-' mol) elicited dose-related decreases of mean arterial pressure (MAP), heart rate (HR), and tidal volume (TV) following NA injection; bremazocine (BREM) decreased MAP, HR, and respiratory rate (RR). Following NTS injection, MRZ (3 x 10-i' to 16 x lo-' mol) lowered MAP and TV, the highest dose also lowering HR and RR; BREM (3 x lo-' to 16 x lo-' mol) decreased MAP and HR. Naloxone (200 pg/kg, i.v.) reversed the respiratory effects of MRZ without consistently altering cardiovascular activity. In ventilated animals, NA injections of MRZ or BREM (3 x 10m9 to 16 x lo-' mol) elicited a dose-related decrease of MAP without altering HR. These responses were not reversed by naloxone. The stereoisomer of BREM (+ BREM) was without effect at similar doses (3 x lo-' to 16 x lo-' mol). MRZ (16 X lo-' mol) elicited a naloxone-reversible tachycardia following NTS injection in ventilated animals; no other cardiovascular responses were observed following NTS administration of BREM (16 x 10m9 mol) or lower doses of MRZ. Dynorphin (l-13) (6 X 10e9 to 60 X lop9 mol) significantly lowered MAP without altering HR following NA microinjections in ventilated animals; the lower dose decreased MAP following NTS injections. These observations suggest that in the NA, the benzomorphan derivatives elicit cardiovascular depressor responses mediated by kappa opioid receptors, whereas the naloxone-sensitive respiratory depression may be mediated in part by mu receptors in the NTS and NA. The selective responses to dynorphin (l-13) in the NTS and NA may indicate the presence of subgroups of kappa receptors in these nuclei.
Opioids elicit complex cardiovascular and respiratory re- (Hassen et al., 1982 (Hassen et al., , 1983 . Anterior hypothalamic injections sponses following central administration (Florez et al., 1968 ; of mu receptor agonists in conscious rats also elicited pressor Laubie et al., 1977; Bolme et al., 1978) . This may be due, in responses and tachycardia (Pfeiffer et al., 1983a, b) . Moreover, part, to multiple opioid receptors which mediate qualitatively the endogenous opioids methionineand leucine-enkephalin different cardiorespiratory responses (Lord et al., 1977 ; Chang elicit cardiovascular responses from the NTS that are quite et al., 1979; Leslie et al., 1980) . Using intraparenchymal injecsimilar to those produced by highly selective mu agonists (Petty tion of relatively selective mu and delta agonists in the rat, we and De Jong, 1983). In contrast, P-endorphin, a selective ligand have found that mu receptors in the region of nucleus tractus for the putative epsilon receptor (Schulz et al., 1981a) , decreases solitarius (NTS) as well as in the region of nucleus ambiguus blood pressure and heart rate following NTS microinjection in (NA) may mediate increases in blood pressure and tachycardia the rat (Petty and De Jong, 1982) . Thus, other opioid receptor types may also function in cardiovascular regulation. ' This work was supported by the Uniformed Services University of NTS and NA also contain dynorphin-immunoreactive pepthe Health Sciences Protocol R09211. The opinions or assertions tides (Khachaturian et al., 1982; Molineaux et al., 1982 ; Feuercontained herein are the private ones of the authors and are not to be stein et al., 1983) . These dynorphin-related peptides exhibit construed as official or reflecting the view of the Department of Defense relative selectivity toward the kappa opioid receptor and have or the Uniformed Services University of the Health Sciences. The been proposed as endogenous ligands for this receptor (Chavkin experiments reported herein were conducted according to the Guiding et al., 1982; Oka et al., 1982; Schulz et al., 1982) . Kappa Principles in the Care and Use of Animals approved by the American receptors have also been localized in the hindbrain (Della Bella Physiological Society. We wish to thank Eleanor M. Bell and Victoria et al., 1978; Pfeiffer and Herz, 1982) . Although dynorphin and Roane for the preparation of this manuscript and to acknowledge the other kappa agonists elicit cardiorespiratory responses followexpert technical assistance of Dan Snyder.
ing hypothalamic microinjection (Feuerstein and Faden, 1982 ; * To whom correspondence should be directed, at his present address: Pfeiffer et al., 1983a, b) , no cardiovascular or respiratory funcDepartment of Physiology, West Virginia School of Osteopathic Med-tion has been ascribed to the kappa system in the hindbrain. icine, 400 North Lee Street, Lewisburg, WV 24901.
In the present study we examined the cardiovascular responses 2213 2214
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to MRZ 2549 and bremazocine, benzomorphan derivatives which are selective for kappa receptors (Romer et al., 1980; Schulz and Wuster, 1981) following microinjection into NTS and NA. To distinguish the respiratory and cardiovascular actions of these compounds, which may be interactive (Bellet et al., 1980; Hassen et al., 1983) , experiments were performed using spontaneously breathing and artificially ventilated animals. The cardiovascular responses to the endogenous dynorphin peptides, dynorphin
(1-13) (Dyn 13) and dynorphin (l-8) (Dyn 8), were examined using artificially ventilated animals. Vol. 4, No. 9, Sept. 1984 ratory) or dynorphin (l-8) (Dyn-8, Peninsula Laboratory) were also microinjected into the two hindbrain regions. Microinjections were administered using a Medical Systems Corporation PPM2 Pneumatic Pump. At the conclusion of the observation period, naloxone (generously provided by Endo Laboratory) was injected intravenously (200 fig/kg ), and the responses were followed for another 15 min. In some experiments animals were monitored for up to 60 min following microinjection of the opioids to exclude any secondary or late onset responses to the opioids. At the conclusion of the experiment, the capillary was raised, filled with saturated fast green solution, and returned to the same stereotaxic coordinates as the injections. The fast green solution was injected to mark the site; the brainstem was removed, frozen on dry ice, mounted on a cryostat, sliced (100 pm) and mounted on a glass slide. Placement of the cannulae was confirmed microscopically (Paxinos and Watson, 1982) .
Materials
and Methods Surgical preparation.
Male Sprague-Dawley rats (250 to 300 gm) were anesthetized with pentobarbital(60 mg/kg, i.p., plus supplemental doses as needed). The femoral artery and vein were cannulated, a tracheal cannula was inserted, and the animal was placed in a Kopf stereotaxic device. The obex was exposed by removing the middle portion of the occipital bone. A pulled glass capillary (outer diameter 14 pm), prebilled with 0.9% saline (vehicle) or opioid solution, was inserted into the brainstem according to the following coordinates measured from the obex: NA, lateral = 1.9 mm, anteroposterior = +1.9 mm, ventral = -2.3 mm from the dorsal surface of the hindbrain; NTS, lateral = 0.5 mm, anteroposterior = obex, ventral = -0.5 mm from the dorsal surface of the hindbrain. Systolic and diastolic blood pressures were obtained through a Narco RP 1500i pressure transducer. Mean arterial pressure (MAP) was calculated as l/3 (pulse pressure) + diastolic pressure. Heart rate (HR) was derived from the arterial recording by means of a Narco Biotachograph. Respiration rate (RR) and relative tidal volume (TV) were recorded with a Narco Impedance Pneumograph. Arterial blood gas was measured using a Corning pH/ Blood Gas 164/2. Rectal temperature was monitored with a thermoprobe (YSI) and was controlled with a heating pad. Artificially respired animals were ventilated with a Harvard Apparatus Rodent Respirator. 
Results
The saturated fast green solution, injected in a larger volume (0.3 ~1) than was used for opioid or saline injections (0.1 ~1) in order to leave a recognizable mark, diffused approximately 500 grn from the injection site. NTS injections spread to the commissural nucleus of the tractus solitarius and the dorsal motor nucleus of the vagus (Fig. l) , whereas NA injections diffused to the NA and the adjacent Al catecholamine group (Fig. 2 ). There was no evidence of diffusion of fast green from one injection site to the other within the experimental period. Moreover, different patterns of cardiorespiratory responses were elicited from the two regions of the hindbrain, a further indication that the two injection sites did not overlap. Microinjections into other hindbrain regions elicited either no cardiorespiratory responses (pyramidal tract caudal to the obex) or responses which were smaller and had longer latencies than There were no differences between treatment groups.
Saline injections had no significant effect on MAP (-2 k 2 mm Hg), HR (-1 + 3 beats/min), or respiration. MRZ elicited dose-related decreases in MAP, HR, and TV (Fig. 3) . Although low doses (3 x 10-l' and 3 x 10-i' mol) produced small decreases in MAP and HR, higher doses (3 x lo-' and 16 x lo-' mol) elicited significant hypotension (-27 + 8 and -24 + 4 mm Hg) and bradycardia (-36 f 7 and -36 + 5 beats/min). In contrast, TV was progressively decreased over the entire range of doses (Fig. 3) ; the decrease ranged from -8 + 3% to -24 + 6% and was not accompanied by significant changes in RR (Fig. 3) . BREM elicited similar but smaller decreases in MAP (-3 + 2 to -12 + 3 mm Hg) and HR (0 to -15 f 3 beats/min), accompanied by small decreases in RR (Fig. 3, A to D) . The ED5, for the decrease in MAP was 5 x 10-l' mol and 7 x 10-i' mol for MRZ and BREM, respectively, ED, for HR changes were 3.5 X lo-" mol and 6 X 10-i' mol, respectively, for MRZ Figure 3 . Cardiovascular and respiratory responses following NA microinjections in spontaneously breathing animals. Measurements were made 15 min after NA microinjection. Solid circles and solid lines refer to MRZ; solid triangles and dashed lines refer to BREM. Hatched areaS delineate the mean f SE of saline-treated animals. The number of animals in each group was as follows: saline, 5; MIU, 3 x 10-l' mol, 6; 3 X 10-l" mol, 6; 3 X 10e9 mol, 6; 16 X 10e9 mol, 6; BREM, 3 X 10-l" mol, 6; 3 x 10e9 mol, 4; 16 x 10e9 mol, 6. **, Different from saline, p < 0.01 (Duncan's Multiple Range Test). *, Different from saline, p < 0.05 (Duncan's Multiple Range Test). $, Different from saline, p c 0.05 (unpaired, two-tailed Student's t test). Vol. 4, No. 9, Sept. 1984 and BREM. Thus, in spite of the different respiratory effects of these compounds, the cardiovascular responses were similar. Cardiovascular and respiratory responses occurred within minutes of the injection and reached a maximum within 15 min. A gradual return to control was observed, and the total response had a duration of less than 30 min. Naloxone administration (200 pg/kg, i.v.) increased RR of MRZ-treated animals but did not consistently change TV (Fig. 4, C and D) . Moreover, neither MAP nor HR was consistently altered by the opioid antagonist (Fig. 4, A and B) .
Artificial respiration.
Base line MAP and HR for this group were 108 f 2 mm Hg and 360 f. 6 beats/min, respectively. The respirator was set at 72 breaths/min; TV was 1.6 ml. Spontaneously respired animals had lower (p < 0.01) pH (7.308 f 0.008) and pOz (60.3 f 1.1 mm Hg) than artificially respired animals (pH 7.376 f 0.006; ~0, 66.5 f 1.7 mm Hg); however, no significant differences in MAP and HR were observed.
Saline injections produced slight increases in MAP and HR. However, both MRZ and BREM elicited dose-related decreases in MAP (Fig. 5) ; MRZ (10 x 1O-9 mol and 16 x 10m9 mol) decreased MAP 16 * 3 and 24 f 3 mm Hg, respectively, and BREM (3 X 10m9 mol) lowered MAP 9 + 2 mm Hg. The higher dose of BREM (16 x /kg ) following NA microinjections to spontaneously breathing animals. Measurements were made 5 min after intravenous injection. Solid circles and solid lines refer to MRZ; solid triangles and dashed lines refer to BREM. Hatched areas delineate the mean + SE of saline-treated animals. The number of animals in each group was as follows: saline, 5; MRZ, 3 X 10-l' mol, 6; 3 x lo-" mol, 6; 3 X 10m9 mol, 6; 16 x 10m9 mol, 4; BREM, 3 X 10-l' mol, 6; 3 X 10m9 mol, 4; 16 x 10m9 mol, 6. **, Different from saline, p < 0.01 (unpaired, two-tailed Student's t test). *, Different from saline, p < 0.05 (unpaired, two-tailed Student's t test. duration of these responses were the same as those of spontaneously breathing animals. Naloxone (200 pg/kg, i.v.) again failed to reverse these responses; however, a slowing of HR was observed. To ascertain whether the absence of reversal by naloxone was dose related, two animals were administered a dose (1 mg/kg, i.v.) 10 times greater than that required to terminate the actions of mu agonists (100 pg/kg); this dose was also without effect (Fig. 6 ). The inactive stereoisomer (+)-bremazocine (3 X lo-' to 16 X 10m9 mol) did not change either MAP (-3 + 2 mm Hg) or HR (-2 f 6 beats/min).
Effect of MRZ and BREM injected into the NTS: Spontaneous respiration.
Pre-injection values for MAP, HR, and RR were 101 + 2 mm Hg, 338 f 6 beats/min, and 70 f 1 breaths/min, respectively. There were no differences between the different groups.
Saline injections had no significant effect on HR and RR or respiration.
High doses of MRZ (3 x 10-l" to 16 X 10m9 mol) decreased MAP and TV (Fig. 7) . HR and RR were decreased following the highest dose of MRZ (16 x lo-' mol). BREM elicited a reduction of TV that was not significantly greater than saline; however, doses of 3 X 10m9 and 16 X 10m9 mol elicited decreased MAP and HR (Fig. 7) .
As was seen with NA injections, the responses occurred within minutes, reached a maximum within 15 min, and had a total duration of less than 30 min. Naloxone (200 pg/kg, i.v.) reversed the depression of TV induced by MRZ and elevated the MAP of both MRZ-and BREM-treated animals; HR responses were not significant (Fig. 8) Hatched areas delineate the mean rt SE of saline-treated animals. The number of animals in each group was as follows: saline, 10; MRZ, 3 x 10-l' mol, 6; 3 X 10m9 mol, 9; 16 X lo-' mol, 6; BREM, 3 X 10-l' mol, and TV was 1.6 ml. There were no differences between the groups. Spontaneously breathing animals had a significantly (p < 0.01) lower pH (7.298 + 0.015) and pOq (61.0 f 1.5 mm Hg) than artificially respired animals (pH 7.363 f 0.002; ~0, 71.1 f 1.8 mm Hg); however, no differences in initial MAP or HR were observed between artificially and spontaneously respired animals.
Saline injections produced no significant change in MAP (-3 f 4 mm Hg) and HR (+2 f 6 beats/min). Doses of MRZ or BREM which elicited significant responses in spontaneously breathing animals were without effect when ventilation was controlled (Fig. 9) . The only significant response was an elevation of HR elicited by the highest dose of MRZ (16 X 10m9 mol). This tachycardia was reversed by a low dose of naloxone (200 wg/kg, i.v.; Fig. 9A ).
Effect of dynorphin microinjections.
In additional experiments, Dyn 13 and Dyn 8 were microinjected into artificially ventilated rats (Table I ). In the NTS Dyn 13 (6 X 10e9 mol) significantly reduced MAP without altering HR. A higher dose (60 x 10m9 mol) had no consistent effect; neither dose of Dyn 8 altered MAP or HR. NA microinjections of Dyn 13 (6 X 10m9 to 60 x 10e9 mol) significantly lowered MAP without changing HR. The responses to Dyn 8 were not significantly different from saline.
Discussion
Martin and co-workers first postulated the existence of kappa receptors which mediate analgesia but whose agonists, the benzomorphan derivatives, do not exhibit cross-tolerance with morphine (Gilbert and Martin, 1976; Martin et al., 1976) . Since these original reports, the function, as well as the distribution, of kappa receptors has been controversial.
In recent years, however, kappa or benzomorphan receptors, as well as endogenous ligands for these receptors, have been demonstrated in the periphery and brain of several species, including rat, mouse, guinea pig, and human (Kosterlitz et al., 1981; Wuster et al., 1981; Maurer, 1982; Pfeiffer and Herz, 1982) . However, kappa receptors may not be a homogenous receptor population; studies of selective development of tolerance to kappa agonists in vitro have demonstrated different degrees of cross-tolerance among the different agonists (Schulz and Wuster, 1981; Schulz et al., 1981b) . Moreover, subclasses of kappa binding have been de-5; 3 X lo-' mol, 6; 16 X 10m9 mol, 7. * *, Different from saline, p < 0.01 (Duncan's Multiple Range Test). *, Different from saline, p < 0.05 (Duncan's Multiple Range Test). $, Different from saline, p < 0.05 (unpaired, two-tailed Student's t test).
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Hatched areas delineate the mean + SE of saline-treated animals.
The number of animals in each group was as follows: saline, 6; MRZ, 3 X 10-l' mol, 6; 3 X 10m9 mol, 8; 16 X 10m9 mol, 4; BREM, 3 x 10-l' mol, 5; 3 x 10e9 mol, 6, 16 x 10e9 mol, 6. **, Different from saline, p < 0. scribed in human and rat brain (Pfeiffer and Herz, 1982; Pfeiffer et al., 1981) .
Dyn 13 and Dyn 8 have been shown to be selectively concentrated within different regions of the brain (Weber et al., 1982) . However, study of the actions of these peptides is complicated because Dyn 13 is rapidly metabolized (Herman et al., 1980; Leslie and Goldstein, 1982) and Dyn 8 exhibits enhanced selectivity toward mu receptors (Schulz et al., 1982) . Therefore, other compounds exhibiting selectivity toward kappa receptors were also used. BREM and MRZ are benzomorphan derivatives which exhibit kappa-like behavior; they produce analgesia but The number of animals in each group was as follows: saline, 7 (naloxone, 6); MRZ, 3 x lo+' mol, 5 (naloxone, 4); 16 x 10e9 mol, 6; BREM, 16 X 10m9 mol, 5. **, Different from saline, p < 0.01 (unpaired, two-tailed Student's t test).
do not elicit the Straub tail phenomenon (a recognizable tail posture elicited by mu but not kappa agonists) in mice and exhibit limited cross-tolerance with morphine (Merz and Stockhaus, 1979; Romer et al., 1980) . BREM does not produce mydriasis in mice, nor has it been reported to affect respiration in rats (Romer et al., 1980) . Binding assays in vitro have shown both compounds binding to kappa receptors; however, binding with high affinity to mu and delta receptors was also observed (Pfeiffer et al., 1981; Wood et al., 1981) . Since BREM exists as an active (-) as well as inactive (+) stereoisomer (Romer et al., 1980) , the enantiomers were used to determine whether responses exhibit stereospecificity.
MRZ, which exhibits limited cross-tolerance with other kappa agonists (Schulz and Wuster, 1981; Schulz et al., 1981b) , was used to ascertain the presence of kappa isoreceptors.
Using a concentrated fast green solution, the injection sites were shown to be localized to the dorsomedial medulla in the area of the nucleus of tractus solitarius caudal to the obex and to the ventrolateral medulla in the area of the NA rostra1 to the obex. The pattern of diffusion was similar to that previously described for injection volumes of less than 0.5 ~1 (Myers, 1966; Zandberg and De Jong, 1977; Matsuguchi et al., 1982 -7 f 10 -6 + 6 -8 f 7 -3 f 6 -2 f 8 u Significant when compared with saline, by ANOVA with repeated measures.
injection site contains neurons commonly ascribed to different nuclei but which are in close proximity to one another. In the dorsomedial site the commissural nucleus of tractus solitarius, the dorsal motor nucleus of the vagus, and the A2 catecholamine group appears to be intermixed (Dennison et al., 1981; Ritchie et al., 1982) , whereas the NA, the lateral reticular nucleus, and the Al catecholamine group are all within or adjacent to the ventrolateral injection area (Armstrong et al., 1982; Rea et al., 1982; Ritchie et al., 1982) . These nuclei are important in both cardiovascular and respiratory regulation; in the rat, vagal cardiac preganglionic neurons originate in the NA as well as the dorsal motor nucleus of the vagus (Dennison et al., 1981; Kalia and Sullivan, 1982; Nosaka et al., 1982) , baroreceptor afferents terminate in the commissural nucleus of tractus solitarius (Ross et al., 1981; Contreras et al., 1982) , and many neurons in both injection sites exhibit respiration-related activity (Cohen, 1979) .
In artificially ventilated animals, Dyn 13 but not Dyn 8 significantly lowered MAP following NA microinjection. MRZ and BREM produced dose-related, naloxone-insensitive decreases in MAP. These responses are stereospecific as the (+)-enantiomer of BREM had no effect. In the NTS only the low dose of Dyn 13 altered MAP. Neither MRZ, BREM, nor the dynorphins consistently altered HR. In the NA bradycardia was elicited by the highest dose of BREM, whereas in the NTS the only response was tachycardia elicited by the highest dose of MRZ. Moreover, in contrast to naloxone's lack of antagonistic activity against the depressor and bradycardic effects of MRZ and BREM, the tachycardia elicited in the NTS by MRZ was reversed by naloxone. Some kappa responses are reversed by low doses of naloxone (Metcalf et al., 1979; Wood and Rackham, 1981) ; however, higher doses of this mu-selective antagonist are usually required (Hutchinson et al., 1975; Pickworth and Sharpe, 1979) . Thus, our observation that doses of naloxone up to 10 times that needed to reverse the cardiovascular actions of mu agonists did not alter the decrease in MAP elicited by the kappa agonists suggests that these responses are mediated by a non-mu receptor, presumably the kappa receptor. The naloxone-sensitive tachycardia elicited by MRZ at high doses in the NTS might have resulted from an interaction of this compound with mu receptors.
Since MAP and HR were decreased by the benzomorphan compounds following NTS injections in spontaneously breathing but not artificially ventilated animals, these cardiovascular responses are probably secondary to respiratory depression. Similar responses were observed by Bellet et al. (1980) following intracisternal administration of opioids in anesthetized rats. In our laboratory, after injection of mu agonists into the NA (Hassen et al., 1983) , respiratory depression was observed, accompanied by a decrease in MAP and HR, masking the pressor responses and tachycardia elicited by mu agonists in artificially respired animals. Such changes, which are associated with hypoxia, hypercapnia, and acidosis (Bellet et al., 1980; Hassen et al., 1983) , may result from direct alteration of cardiac or vascular activity or from a modification of cardiovascular responses by chemoreceptor reflexes. Decreased thoracic movements associated with respiration may also contribute to an alteration of cardiac output. These observations serve to emphasize the importance of using artificially ventilated animals when studying the cardiovascular responses to opioids because such responses may be substantially changed by the concomitant respiratory effects of these drugs. The cardiovascular and respiratory responses elicited by MRZ following NTS and NA microinjections differ from those seen following intracerebroventricular injections in awake, freely moving rats (Pfeiffer et al., 1983b) . Although no respiratory responses were observed in the latter preparation, MRZ elicited an increase in MAP and HR. The pressor response was not altered by pretreatment with the long-lasting mu antagonist p-funaltrexamine but was antagonized by the kappa antagonist MR 2266. The increase in HR was attenuated by both antagonists. The different responses elicited from anesthetized and awake animals may be due, in part, to the presence of anesthesia, since pentobarbital may alter autonomic activity (Murthy et al., 1982; Zumpfer et al., 1982) . Alternatively, as shown previously (Faden and Feuerstein, 1983) and in the present study, opioid responses are site-specific.
Thus, the responses following intracerebroventricular injections may be due to a summation of cardiovascular effects elicited from multiple sites. In addition to the cardiovascular effect, MRZ was a potent respiratory depressant, and BREM also elicited small decreases in respiration.
Unlike mu agonists, which decreased TV when injected into the NTS but not the NA (Hassen et al., 1982 (Hassen et al., , 1983 , injections of MRZ into both nuclei elicited dose-related decreases in TV. In addition, MRZ and mu agonists had qualitatively different effects on respiratory rate. MRZ, except for a decrease in rate following high doses injected into the NTS, was without effect, whereas the highly selective mu agonist DAla', MePhe", Gly-01' enkephalin (DAGO) and the relative delta-mu antagonist D-Ala*, D-Leu5 enkephalin (DADL) elicited dose-related changes in respiratory rate from both NTS and NA. In contrast to the lack of a naloxone antagonism of the cardiovascular depressor responses, the respiratory effects of MRZ were reversed by low doses of naloxone. Although the sensitivity to naloxone appears to suggest that the respiratory actions of MRZ result from interactions with mu receptors in
